Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Dec;119(7):1427–1437. doi: 10.1111/j.1476-5381.1996.tb16055.x

Endothelin-1 mediated inhibition of the acetylcholine-activated potassium current from rabbit isolated atrial cardiomyocytes.

J P Spiers 1, E J Kelso 1, B J McDermott 1, C N Scholfield 1, B Silke 1
PMCID: PMC1915821  PMID: 8968552

Abstract

1. Endothelin-1 is a 21 amino acid peptide with potent inotropic and chronotropic actions in the heart. Relatively little is known about the underlying electrophysiological effects of the peptide. In this study, the effects of endothelin-1 (ET-1) on the acetylcholine-activated potassium current (IK(ACh) were investigated in the absence and presence of the receptor-selective antagonists, PD155080 (ETA receptor-selective) and RES-701 (ETB receptor-selective) in rabbit atrial cardiomyocytes. 2. Cells were obtained from New Zealand White rabbits (2.5-3 kg) by enzymatic dissociation with collagenase. Potassium currents were recorded, in the presence of nifedipine (5 microM), by use of the whole cell ruptured patch-clamp technique. Following stabilization, control recordings were made with standard pulse protocols, and drugs were applied by a gravity fed microperfusion system. 3. Endothelin-1 (10 nM) alone did not affect the "steady state' potassium current. Acetylcholine (1 microM) increased (P < 0.05) the potassium current to-1321 +/- 290 pA, from a control value of -955 +/- 191 pA, at a step potential of -100 mV. Acetylcholine also increased the holding current at -40 mV from +80 +/- 9 pA to +242 +/- 38 pA, and this effect was abolished (P < 0.05) in the presence of endothelin-1 (+44 +/- 13 pA). The responses to acetylcholine were attributed to activation of the atrial muscarinic-activated potassium current (IK(ACh)) as they were blocked by atropine (10 microM). Endothelin-1 (10 nM) in the presence of acetylcholine did not affect the "steady state' potassium current (-882 +/- 88 pA compared to a control value of -870 +/- 98 pA, at -100 mV). 4. The ETA receptor-selective antagonist, PD155080 (1 microM), prevented (P < 0.05) the ET-1 induced inhibition of IK(ACh) at all potentials. PD155080, in the presence of endothelin-1 and acetylcholine, increased the inward component of the "steady state' potassium current to -1030 +/- 210 pA from a control value of -804 +/- 224 pA at a step potential of -100 mV. Also the outward component was increased at a potential of -20 mV from +90 +/- 17 pA to +241 +/- 47 pA. 5. Unlike PD155080, the ETB receptor-selective antagonist, RES-701 (1 microM), only prevented (P < 0.05) the inhibitory effect of endothelin-1 on the inward component of the IK(ACh); at -100 mV, RES-701, in the presence of endothelin-1 and acetylcholine, increased the "steady state' potassium current to -913 +/- 137 pA from -733 +/- 116 pA. Furthermore, RES-701, in contrast to PD155080, failed to sustain this inhibitory effect as, in the presence of endothelin-1 and acetylcholine, the "steady state' potassium current returned to a value of -768 +/- 96 pA, at a step potential of -100 mV. 6. In conclusion, endothelin-1 clearly inhibits the effects of acetylcholine on IK(ACh) in rabbit atrial cardiomyocytes. This effect is primarily mediated by an ETA receptor-subtype, but is transiently and partially mediated by a RES-701-sensitive ETB receptor subtype. Inhibition of the IK(ACh) may account for the positive chronotropic properties of endothelin-1.

Full text

PDF
1427

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 1990 Dec 20;348(6303):730–732. doi: 10.1038/348730a0. [DOI] [PubMed] [Google Scholar]
  2. Belardinelli L., Isenberg G. Isolated atrial myocytes: adenosine and acetylcholine increase potassium conductance. Am J Physiol. 1983 May;244(5):H734–H737. doi: 10.1152/ajpheart.1983.244.5.H734. [DOI] [PubMed] [Google Scholar]
  3. Bkaily G., Wang S., Bui M., Ménard D. ET-1 stimulates Ca2+ currents in cardiac cells. J Cardiovasc Pharmacol. 1995;26 (Suppl 3):S293–S296. [PubMed] [Google Scholar]
  4. Bogoyevitch M. A., Glennon P. E., Sugden P. H. Endothelin-1, phorbol esters and phenylephrine stimulate MAP kinase activities in ventricular cardiomyocytes. FEBS Lett. 1993 Feb 15;317(3):271–275. doi: 10.1016/0014-5793(93)81291-7. [DOI] [PubMed] [Google Scholar]
  5. Bogoyevitch M. A., Parker P. J., Sugden P. H. Characterization of protein kinase C isotype expression in adult rat heart. Protein kinase C-epsilon is a major isotype present, and it is activated by phorbol esters, epinephrine, and endothelin. Circ Res. 1993 Apr;72(4):757–767. doi: 10.1161/01.res.72.4.757. [DOI] [PubMed] [Google Scholar]
  6. Carmeliet E., Mubagwa K. Characterization of the acetylcholine-induced potassium current in rabbit cardiac Purkinje fibres. J Physiol. 1986 Feb;371:219–237. doi: 10.1113/jphysiol.1986.sp015970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Clarke J. G., Benjamin N., Larkin S. W., Webb D. J., Davies G. J., Maseri A. Endothelin is a potent long-lasting vasoconstrictor in men. Am J Physiol. 1989 Dec;257(6 Pt 2):H2033–H2035. doi: 10.1152/ajpheart.1989.257.6.H2033. [DOI] [PubMed] [Google Scholar]
  8. Cocks T. M., Faulkner N. L., Sudhir K., Angus J. Reactivity of endothelin-1 on human and canine large veins compared with large arteries in vitro. Eur J Pharmacol. 1989 Nov 14;171(1):17–24. doi: 10.1016/0014-2999(89)90425-1. [DOI] [PubMed] [Google Scholar]
  9. Doherty A. M., Patt W. C., Repine J., Edmunds J. J., Berryman K. A., Reisdorph B. R., Walker D. M., Haleen S. J., Keiser J. A., Flynn M. A. Structure-activity relationships of a novel series of orally active nonpeptide ETA and ETA/B endothelin receptor-selective antagonists. J Cardiovasc Pharmacol. 1995;26 (Suppl 3):S358–S361. [PubMed] [Google Scholar]
  10. Galron R., Kloog Y., Bdolah A., Sokolovsky M. Different pathways of endothelin/sarafotoxin-stimulated phosphoinositide hydrolysis in myocytes. Eur J Pharmacol. 1990 Jan 23;188(1):85–88. doi: 10.1016/0922-4106(90)90251-r. [DOI] [PubMed] [Google Scholar]
  11. Habuchi Y., Tanaka H., Furukawa T., Tsujimura Y., Takahashi H., Yoshimura M. Endothelin enhances delayed potassium current via phospholipase C in guinea pig ventricular myocytes. Am J Physiol. 1992 Feb;262(2 Pt 2):H345–H354. doi: 10.1152/ajpheart.1992.262.2.H345. [DOI] [PubMed] [Google Scholar]
  12. Hagiwara N., Irisawa H., Kameyama M. Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J Physiol. 1988 Jan;395:233–253. doi: 10.1113/jphysiol.1988.sp016916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hamill O. P., Marty A., Neher E., Sakmann B., Sigworth F. J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981 Aug;391(2):85–100. doi: 10.1007/BF00656997. [DOI] [PubMed] [Google Scholar]
  14. Hartzell H. C., Simmons M. A. Comparison of effects of acetylcholine on calcium and potassium currents in frog atrium and ventricle. J Physiol. 1987 Aug;389:411–422. doi: 10.1113/jphysiol.1987.sp016663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hom G. J., Touhey B., Rubanyi G. M. Effects of intracoronary administration of endothelin in anesthetized dogs: comparison with Bay k 8644 and U 46619. J Cardiovasc Pharmacol. 1992 Feb;19(2):194–200. doi: 10.1097/00005344-199202000-00007. [DOI] [PubMed] [Google Scholar]
  16. Honjo H., Kodama I., Zang W. J., Boyett M. R. Desensitization to acetylcholine in single sinoatrial node cells isolated from rabbit hearts. Am J Physiol. 1992 Dec;263(6 Pt 2):H1779–H1789. doi: 10.1152/ajpheart.1992.263.6.H1779. [DOI] [PubMed] [Google Scholar]
  17. Ishikawa T., Li L. M., Shinmi O., Kimura S., Yanagisawa M., Goto K., Masaki T. Characteristics of binding of endothelin-1 and endothelin-3 to rat hearts. Developmental changes in mechanical responses and receptor subtypes. Circ Res. 1991 Oct;69(4):918–926. doi: 10.1161/01.res.69.4.918. [DOI] [PubMed] [Google Scholar]
  18. Ishikawa T., Yanagisawa M., Kimura S., Goto K., Masaki T. Positive chronotropic effects of endothelin, a novel endothelium-derived vasoconstrictor peptide. Pflugers Arch. 1988 Nov;413(1):108–110. doi: 10.1007/BF00581239. [DOI] [PubMed] [Google Scholar]
  19. Ishikawa T., Yanagisawa M., Kimura S., Goto K., Masaki T. Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea pig atria. Am J Physiol. 1988 Oct;255(4 Pt 2):H970–H973. doi: 10.1152/ajpheart.1988.255.4.H970. [DOI] [PubMed] [Google Scholar]
  20. Kelly R. A., Eid H., Krämer B. K., O'Neill M., Liang B. T., Reers M., Smith T. W. Endothelin enhances the contractile responsiveness of adult rat ventricular myocytes to calcium by a pertussis toxin-sensitive pathway. J Clin Invest. 1990 Oct;86(4):1164–1171. doi: 10.1172/JCI114822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kelso E. J., McDermott B. J., Silke B. Actions of the novel vasodilator, flosequinan, in isolated ventricular cardiomyocytes. J Cardiovasc Pharmacol. 1995 Mar;25(3):376–386. doi: 10.1097/00005344-199503000-00005. [DOI] [PubMed] [Google Scholar]
  22. Kim D. Endothelin activation of an inwardly rectifying K+ current in atrial cells. Circ Res. 1991 Jul;69(1):250–255. doi: 10.1161/01.res.69.1.250. [DOI] [PubMed] [Google Scholar]
  23. Kim D., Lewis D. L., Graziadei L., Neer E. J., Bar-Sagi D., Clapham D. E. G-protein beta gamma-subunits activate the cardiac muscarinic K+-channel via phospholipase A2. Nature. 1989 Feb 9;337(6207):557–560. doi: 10.1038/337557a0. [DOI] [PubMed] [Google Scholar]
  24. Kim D. Mechanism of rapid desensitization of muscarinic K+ current in adult rat and guinea pig atrial cells. Circ Res. 1993 Jul;73(1):89–97. doi: 10.1161/01.res.73.1.89. [DOI] [PubMed] [Google Scholar]
  25. Kobayashi S., Nakaya H., Takizawa T., Hara Y., Kimura S., Saito T., Masuda Y. Endothelin-1 partially inhibits ATP-sensitive K+ current in guinea pig ventricular cells. J Cardiovasc Pharmacol. 1996 Jan;27(1):12–19. doi: 10.1097/00005344-199601000-00003. [DOI] [PubMed] [Google Scholar]
  26. Krämer B. K., Smith T. W., Kelly R. A. Endothelin and increased contractility in adult rat ventricular myocytes. Role of intracellular alkalosis induced by activation of the protein kinase C-dependent Na(+)-H+ exchanger. Circ Res. 1991 Jan;68(1):269–279. doi: 10.1161/01.res.68.1.269. [DOI] [PubMed] [Google Scholar]
  27. Kurachi Y. G protein regulation of cardiac muscarinic potassium channel. Am J Physiol. 1995 Oct;269(4 Pt 1):C821–C830. doi: 10.1152/ajpcell.1995.269.4.C821. [DOI] [PubMed] [Google Scholar]
  28. Kurachi Y., Nakajima T., Sugimoto T. On the mechanism of activation of muscarinic K+ channels by adenosine in isolated atrial cells: involvement of GTP-binding proteins. Pflugers Arch. 1986 Sep;407(3):264–274. doi: 10.1007/BF00585301. [DOI] [PubMed] [Google Scholar]
  29. Lauer M. R., Gunn M. D., Clusin W. T. Endothelin activates voltage-dependent Ca2+ current by a G protein-dependent mechanism in rabbit cardiac myocytes. J Physiol. 1992 Mar;448:729–747. doi: 10.1113/jphysiol.1992.sp019067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Masaki T., Vane J. R., Vanhoutte P. M. International Union of Pharmacology nomenclature of endothelin receptors. Pharmacol Rev. 1994 Jun;46(2):137–142. [PubMed] [Google Scholar]
  31. Miyauchi T., Doi T., Suzuki N., Kakihana M., Yamaguchi I., Sugishita Y., Mitsui T., Hori M., Masaki T., Goto K. Plasma endothelin-1 concentrations in the coronary sinus in dogs with artificially induced myocardial infarction. Peptides. 1992 Sep-Oct;13(5):1013–1015. doi: 10.1016/0196-9781(92)90064-a. [DOI] [PubMed] [Google Scholar]
  32. Miyoshi Y., Nakaya Y., Wakatsuki T., Nakaya S., Fujino K., Saito K., Inoue I. Endothelin blocks ATP-sensitive K+ channels and depolarizes smooth muscle cells of porcine coronary artery. Circ Res. 1992 Mar;70(3):612–616. doi: 10.1161/01.res.70.3.612. [DOI] [PubMed] [Google Scholar]
  33. Moravec C. S., Reynolds E. E., Stewart R. W., Bond M. Endothelin is a positive inotropic agent in human and rat heart in vitro. Biochem Biophys Res Commun. 1989 Feb 28;159(1):14–18. doi: 10.1016/0006-291x(89)92397-8. [DOI] [PubMed] [Google Scholar]
  34. Nichols A. J., Koster P. F., Ohlstein E. H. The effect of diltiazem on the coronary haemodynamic and cardiac functional effects produced by intracoronary administration of endothelin-1 in the anaesthetized dog. Br J Pharmacol. 1990 Mar;99(3):597–601. doi: 10.1111/j.1476-5381.1990.tb12975.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Ono K., Eto K., Sakamoto A., Masaki T., Shibata K., Sada T., Hashimoto K., Tsujimoto G. Negative chronotropic effect of endothelin 1 mediated through ETA receptors in guinea pig atria. Circ Res. 1995 Feb;76(2):284–292. doi: 10.1161/01.res.76.2.284. [DOI] [PubMed] [Google Scholar]
  36. Ono K., Tsujimoto G., Sakamoto A., Eto K., Masaki T., Ozaki Y., Satake M. Endothelin-A receptor mediates cardiac inhibition by regulating calcium and potassium currents. Nature. 1994 Jul 28;370(6487):301–304. doi: 10.1038/370301a0. [DOI] [PubMed] [Google Scholar]
  37. Pfaffinger P. J., Martin J. M., Hunter D. D., Nathanson N. M., Hille B. GTP-binding proteins couple cardiac muscarinic receptors to a K channel. Nature. 1985 Oct 10;317(6037):536–538. doi: 10.1038/317536a0. [DOI] [PubMed] [Google Scholar]
  38. Reid J. J., Wong-Dusting H. K., Rand M. J. The effect of endothelin on noradrenergic transmission in rat and guinea-pig atria. Eur J Pharmacol. 1989 Sep 1;168(1):93–96. doi: 10.1016/0014-2999(89)90637-7. [DOI] [PubMed] [Google Scholar]
  39. Sakamoto A., Yanagisawa M., Sakurai T., Takuwa Y., Yanagisawa H., Masaki T. Cloning and functional expression of human cDNA for the ETB endothelin receptor. Biochem Biophys Res Commun. 1991 Jul 31;178(2):656–663. doi: 10.1016/0006-291x(91)90158-4. [DOI] [PubMed] [Google Scholar]
  40. Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Kimura S., Goto K., Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 1990 Dec 20;348(6303):732–735. doi: 10.1038/348732a0. [DOI] [PubMed] [Google Scholar]
  41. Salvati P., Chierchia S., Dho L., Ferrario R. G., Parenti P., Vicedomini G., Patrono C. Proarrhythmic activity of intracoronary endothelin in dogs: relation to the site of administration and to changes in regional flow. J Cardiovasc Pharmacol. 1991 Jun;17(6):1007–1014. doi: 10.1097/00005344-199106000-00022. [DOI] [PubMed] [Google Scholar]
  42. Soejima M., Noma A. Mode of regulation of the ACh-sensitive K-channel by the muscarinic receptor in rabbit atrial cells. Pflugers Arch. 1984 Apr;400(4):424–431. doi: 10.1007/BF00587544. [DOI] [PubMed] [Google Scholar]
  43. Takanashi M., Endoh M. Characterization of positive inotropic effect of endothelin on mammalian ventricular myocardium. Am J Physiol. 1991 Sep;261(3 Pt 2):H611–H619. doi: 10.1152/ajpheart.1991.261.3.H611. [DOI] [PubMed] [Google Scholar]
  44. Tanaka T., Tsukuda E., Nozawa M., Nonaka H., Ohno T., Kase H., Yamada K., Matsuda Y. RES-701-1, a novel, potent, endothelin type B receptor-selective antagonist of microbial origin. Mol Pharmacol. 1994 Apr;45(4):724–730. [PubMed] [Google Scholar]
  45. Varró A., Nánási P. P., Lathrop D. A. Voltage-clamp characteristics of ventricular myocytes in rabbit. Cardioscience. 1991 Dec;2(4):233–243. [PubMed] [Google Scholar]
  46. Vogelsang M., Broede-Sitz A., Schäfer E., Zerkowski H. R., Brodde O. E. Endothelin ETA-receptors couple to inositol phosphate formation and inhibition of adenylate cyclase in human right atrium. J Cardiovasc Pharmacol. 1994 Feb;23(2):344–347. [PubMed] [Google Scholar]
  47. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]
  48. Yang X. P., Madeddu P., Micheletti R., English E., Rossi R., Giacalone G., Benatti P., Bianchi G. Effects of intravenous endothelin on hemodynamics and cardiac contractility in conscious Milan normotensive rats. J Cardiovasc Pharmacol. 1991 Apr;17(4):662–669. doi: 10.1097/00005344-199104000-00021. [DOI] [PubMed] [Google Scholar]
  49. Yasuda M., Kohno M., Tahara A., Itagane H., Toda I., Akioka K., Teragaki M., Oku H., Takeuchi K., Takeda T. Circulating immunoreactive endothelin in ischemic heart disease. Am Heart J. 1990 Apr;119(4):801–806. doi: 10.1016/s0002-8703(05)80315-1. [DOI] [PubMed] [Google Scholar]
  50. Yatani A., Okabe K., Polakis P., Halenbeck R., McCormick F., Brown A. M. ras p21 and GAP inhibit coupling of muscarinic receptors to atrial K+ channels. Cell. 1990 Jun 1;61(5):769–776. doi: 10.1016/0092-8674(90)90187-j. [DOI] [PubMed] [Google Scholar]
  51. Yatani A., Quilliam L. A., Brown A. M., Bokoch G. M. Rap1A antagonizes the ability of Ras and Ras-Gap to inhibit muscarinic K+ channels. J Biol Chem. 1991 Nov 25;266(33):22222–22226. [PubMed] [Google Scholar]
  52. Yorikane R., Shiga H., Miyake S., Koike H. Evidence for direct arrhythmogenic action of endothelin. Biochem Biophys Res Commun. 1990 Nov 30;173(1):457–462. doi: 10.1016/s0006-291x(05)81080-0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES